U.S. Intravenous Immunoglobulin (IVIG) Market Projected to Reach USD 10.2 Million by 2027 Rising Prevalence of Immunodeficiency Disorders and FDA Approvals Drive Market Expansion The U.S. Intravenous Immunoglobulin (IVIG) Market Size is experiencing significant growth, with its valuation expected to increase from USD 6.48 million in 2020 to approximately USD 10.2 million by 2027,...